3TC and protease inhibitors: citizen's petition asks faster approval. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


3TC and protease inhibitors: citizen's petition asks faster approval. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Treat News. 1995 Apr 7;(no 220):5. Unique Identifier : AIDSLINE AIDS/95700344

Abstract: Log Cabin Republicans, a gay and lesbian Republican organization, has formally petitioned the Food and Drug Administration (FDA) to speed approval of three drugs: 3TC, saquinavir, and MK-639. The petition also explores the possibility of approving critical drugs as soon as they are ready for expanded access. The FDA's David Feigal met with petitioners on March 28 to discuss practical obstacles to approval.
Keywords: Drug Approval/*LEGISLATION & JURISPRUD Human HIV Protease Inhibitors/*THERAPEUTIC USE Pyridines/*THERAPEUTIC USE United States United States Food and Drug Administration Zalcitabine/ANALOGS & DERIVATIVES/*THERAPEUTIC USE NEWSLETTER ARTICLE

KWDdrugapproval/KWDlegislation&jurisprudhumanhivproteaseinhibitors/KWDtherapeuticusepyridines/KWDtherapeuticuseunitedstatesunitedstatesfoodanddrugadministrationzalcitabine/analogs&derivatives/KWDtherapeuticusenewsletterarticle
951130
M95B0911

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .